Panacea Biotec share price jumps on UNICEF contract upgrade
after close1 source ↓written by the desknot a recommendation
Panacea Biotec Limited reported a significant upgrade to its UNICEF vaccine supply contract, boosting its share price sharply on 26 December 2025. The change involves increased order values for the WHO pre-qualified pentavalent vaccine (Easyfive‑TT®), enhancing revenue visibility for 2026 and 2027. This development has led to heavy trading volumes and positive market sentiment.
Not investment advice. For informational purposes only.